Clinical Trial Update: Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adequatrelimab with bevacizumab and docetaxel in advanced non-squamous non-small cell lung cancer after progression on first-line immun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: The First Affiliated Hospital of Xinxiang Medical College | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN